AbbVie Inc.
MX ˙ BMV ˙ US00287Y1091
SecurityMX:ABBV / AbbVie Inc.
InstitutionPeddock Capital Advisors, Llc
Latest Disclosed Ownership2,850 shares
Latest Disclosed Value $ 619,771
Peddock Capital Advisors, Llc reports 0.07% decrease in ownership of ABBV / AbbVie Inc.

On April 15, 2026 - Peddock Capital Advisors, Llc filed a 13F-HR form disclosing ownership of 2,850 shares of AbbVie Inc. (MX:ABBV) valued at $619,771 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 2,852 shares of AbbVie Inc.. This represents a change in shares of -0.07% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F ABBVIE COM 00287Y109 2,850 -2 -0.07 620 -4.92 0.1367
2026-01-21 2025-12-31 13F ABBVIE COM 00287Y109 2,852 67 2.41 652 1.09 0.1365
2025-10-17 2025-09-30 13F ABBVIE COM 00287Y109 2,785 23 0.83 645 25.78 0.1390
2025-07-15 2025-06-30 13F ABBVIE COM 00287Y109 2,762 -10 -0.36 513 -11.72 0.1186
2025-04-30 2025-03-31 13F ABBVIE COM 00287Y109 2,772 35 1.28 581 19.34 0.1471
2025-01-13 2024-12-31 13F ABBVIE COM 00287Y109 2,737 -1,296 -32.13 486 -38.94 0.1166
2024-10-08 2024-09-30 13F ABBVIE COM 00287Y109 4,033 0 0.00 796 15.20 0.1915
2024-07-18 2024-06-30 13F ABBVIE COM 00287Y109 4,033 33 0.82 692 -5.08 0.1781
2024-05-03 2024-03-31 13F ABBVIE COM 00287Y109 4,000 -4 -0.10 728 17.42 0.1908
2024-02-06 2023-12-31 13F ABBVIE COM 00287Y109 4,004 35 0.88 620 4.91 0.1890
2023-10-10 2023-09-30 13F ABBVIE COM 00287Y109 3,969 2 0.05 592 10.67 0.1973
2023-08-07 2023-06-30 13F ABBVIE COM 00287Y109 3,967 141 3.69 535 -12.32 0.1758
2023-05-04 2023-03-31 13F ABBVIE COM 00287Y109 3,826 347 9.97 610 8.36 0.2118
2023-02-02 2022-12-31 13F ABBVIE COM 00287Y109 3,479 -630 -15.33 562 2.00 0.2176
2022-11-14 2022-09-30 13F ABBVIE COM 00287Y109 4,109 76 1.88 551 -10.84 0.2263
2022-08-01 2022-06-30 13F ABBVIE COM 00287Y109 4,033 -56 -1.37 618 -6.79 0.2418
2022-05-16 2022-03-31 13F ABBVIE COM 00287Y109 4,089 1 0.02 663 19.68 0.2149
2022-02-08 2021-12-31 13F ABBVIE COM 00287Y109 4,088 -199 -4.64 554 19.91 0.1830
2021-11-15 2021-09-30 13F AbbVie COM 00287Y109 4,287 -991 -18.78 462 -24.76 0.1646
2021-08-16 2021-06-30 13F AbbVie COM 00287Y109 5,278 -5 -0.09 614 7.34 0.2146
2021-05-17 2021-03-31 13F AbbVie COM 00287Y109 5,283 201 3.96 572 4.95 0.2185
2021-02-12 2020-12-31 13F AbbVie COM 00287Y109 5,082 0 0.00 545 22.47 0.2838
2020-11-16 2020-09-30 13F AbbVie COM 00287Y109 5,082 -128 -2.46 445 -12.92 0.2727
2020-08-11 2020-06-30 13F AbbVie COM 00287Y109 5,210 1,860 55.52 511 100.39 0.3223
2020-05-13 2020-03-31 13F AbbVie COM 00287Y109 3,350 0 0.00 255 -14.14 0.1907
2020-01-24 2019-12-31 13F AbbVie COM 00287Y109 3,350 0 0.00 297 16.93 0.1521
2019-10-15 2019-09-30 13F AbbVie COM 00287Y109 3,350 0 0.00 254 4.10 0.1410
2019-08-06 2019-06-30 13F AbbVie COM 00287Y109 3,350 0 0.00 244 -9.63 0.1299
2019-05-14 2019-03-31 13F AbbVie COM 00287Y109 3,350 0 0.00 270 -12.62 0.1462
2019-02-13 2018-12-31 13F AbbVie COM 00287Y109 3,350 0 0.00 309 -2.52 0.1833
2018-11-13 2018-09-30 13F ABBVIE INC COM Stock 00287Y109 3,350 0 0.00 317 2.26 0.1527
2018-08-03 2018-06-30 13F ABBVIE INC COM Stock 00287Y109 3,350 0 0.00 310 -2.21 0.1551
2018-05-04 2018-03-31 13F ABBVIE INC COM Stock 00287Y109 3,350 0 0.00 317 -2.16 0.1671
2018-02-02 2017-12-31 13F AbbVie COM 00287Y109 3,350 0 0.00 324 8.72 0.1624
2017-11-14 2017-09-30 13F AbbVie COM 00287Y109 3,350 0 0.00 298 22.63 0.1527
2017-08-04 2017-06-30 13F AbbVie COM 00287Y109 3,350 0 0.00 243 11.47 0.1290
2017-05-05 2017-03-31 13F AbbVie COM 00287Y109 3,350 0 0.00 218 3.81 0.1260
2017-02-03 2016-12-31 13F AbbVie COM 00287Y109 3,350 -503 -13.05 210 -13.58 0.1231
2016-10-14 2016-09-30 13F AbbVie COM 00287Y109 3,853 0 0.00 243 1.67 0.1494
2016-07-15 2016-06-30 13F ABBVIE COM 00287Y109 3,853 3,853 0.00 239 0.1525
2016-04-19 2016-03-31 13F ABBVIE COM 00287Y109 0 -3,368 -100.00 0 -100.00
2016-01-19 2015-12-31 13F ABBVIE COM 00287Y109 3,368 3,368 0.00 200 0.1531
2015-10-19 2015-09-30 13F ABBVIE COM 00287Y109 0 -3,350 -100.00 0 -100.00
2015-07-23 2015-06-30 13F ABBVIE COM 00287Y109 3,350 3,350 0.00 225 0.1833
2015-04-16 2015-03-31 13F ABBVIE COM 00287Y109 0 -3,350 -100.00 0 -100.00
2015-01-14 2014-12-31 13F ABBVIE COM 00287Y109 3,350 3,350 219 0.1773
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.